Drug Type Small molecule drug |
Synonyms + [1] |
Target |
Mechanism DHFR inhibitors(Dihydrofolate reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H23N5O2 |
InChIKeyNMARPFMJVCXSAV-UHFFFAOYSA-N |
CAS Registry73090-70-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Preclinical | US | 01 Jul 1993 | |
Pneumonia | Preclinical | - | - | |
Pneumonia, Pneumocystis | Preclinical | CH | - | |
Toxoplasmosis | Preclinical | CH | - |